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In man, gene products of the major histocompatibility complex (MHC) are involved 
in the T-cell-mediated cytotoxicity directed to minor histoeompatibility antigens. In 
a previous publication, we demonstrated that self HLA antigens were required to 
obtain cell-mediated cytotoxicity directed to the male-associated antigen, H-Y. (1, 2). 
Analogous restriction phenomena in man have also been shown for virus-infected 
target cells and for DNCB-modified target cells (3, 4). 
To explain the restriction phenomenon, two hypotheses have been put forward (5). 
According to one hypothesis (altered self) the antigens recognized can be regarded as 
neoantigens created by molecular interactions between self compatible HLA-A, -B, or 
-C gene product and the foreign antigen. This altered self concept is a logical 
consequence of classical theories of immunology such as the clonal selection theory 
(6, 7), and this interpretation is favored by some investigators (8, 9). According to 
another hypothesis (dual recognition) the antigens are seen by cells which have two 
receptors; one recognizes elf compatible HLA-A, -B, or -C, and the other recognizes 
the foreign antigen. This concept is supported by other authors (10-13) but at the 
present moment a firm choice cannot be made between these two hypotheses. 
Whichever is true, two aspects of the specificity of T-cell recognition in cell-mediated 
lympholysis (CML) are important o evaluate. First, is the anti-self or altered-self 
reaction clonal implying the existence of multiple populations of specific immune cells 
(14, 15)? Second, is the anti-self or altered-self reaction attributable to lymphocytes 
with polyvalent speeificities as suggested by others (16)? The discovery of a case of 
HLA-restricted CML reactivity directed to the H-Y antigen in which the killing was 
restricted by a requirement either for self HLA-A2 or B7, and the development of a 
monolayer absorption technique by one of us (15), gave us the opportunity to answer 
these questions. 
Materials and Methods 
Lymphocytes oftwo female patients (patients A and B) were used. The HLA-restricted H-Y 
killing phenomenon as described in previous tudies was demonstrated in both (2, 17). In 
reference 17, patient 1 is equivalent to patient A and patient B is the individual referred to as 
the third patient. Patients A and B were both suffering from aplastic anemia nd had received 
multiple transfusions, a situation which severely limited our access to materials. Lymphocytes 
from A and B were cultured for 6 d with lymphoeytes from HLA-A, -B, and -C identical, but 
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HLA-D different male individuals. After this in vitro sensitization, specific anti-HLA-A2-H-Y 
cytotoxic ells were generated in the case of patient A (17). Patient B formed cytotoxic ells 
which specifically recognized HLA-A2 male target cells and HLA-B7 male target cells (Table 
II). We demonstrated, that the effector cells of the patients tudied retained their specificities 
for HLA-A2 males for a long period of time and that by recalling immunological memory 
(using lymphocytes from HLA-D different unrelated male donors) it was possible to reinduce 
high levels of specific killing (17). After culturing, the sensitized effector cells were overlaid on 
monolayers, according to the techniques described elsewhere (15), which were based on the 
mouse system introduced by Brondz et al. (16). The nonadherent cells were removed and tested 
on a panel of target cells, which had been incubated with phytohemagglutinin for 3 d and then 
labeled with sodium Slchromate. Cytotoxicity as exemplified in Tables I and III, was measured 
and calculated as a percentage according to the methods described elsewhere (17). 
Preparation of the Monolayer. Monolayers were made of fresh peripheral blood lymphocytes 
adhered to Petri dishes treated with poly-L-lysine; the nonadherent cells were removed after 1 
h at room temperature. The effector cells were overlaid and incubated for 1 h at 37°C and 
nonadherent cells were removed and tested (reference 15). The calculation of the depletion of 
cytotoxicity, referred to in the text, was calculated as a percentage of the unabsorbed population. 
Results 
After 6 d of in vitr O sensitization, the responder cells of patient A reacted specifically 
against HLA-A2 males, as illustrated in Table I and in reference 1. These were 
absorbed on four different monolayers, which were numbered one to four and were, 
respectively, HLA-A2 male, non-HLA-A2 male, HLA-A2 female, non-HLA-A2 fe- 
male. The nonadherent cells were removed and tested on a panel of unrelated target 
cells, in which the same specificities were represented. 
Effector cells absorbed on monolayer 1 (HLA-A2 male) gave strongly reduced 
cytotoxic activity directed to all HLA-A2 male-positive target cells. The depletion 
varied from 47 to 64%. Absorption on monolayer 2 (non-HLA-A2 male), 3 (HLA-A2 
female), and 4 (non-HLA-A2 female) showed no significant reduction in cytolysis 
(Table I). These results illustrated that only the appropriate monolayer, i.e. an HLA- 
A2 male monolayer, could absorb the specific killer cells. 
Patient B lymphocytes showed cytotoxic activity against wo independent pheno- 
types namely, HLA-A2 and HLA-B7 male target cells (Table II). Using these cells, 
we investigated whether it was possible to specifically absorb one clone of cytotoxic 
cells and leave the other intact, thus demonstrating the clonal expression of these 
specific killer cells. Table II I  showed that when effector cells recovered from monolayer 
1 (HLA-A2 male) were tested on the panel of target cells, almost complete removal of 
the cytotoxic activity could be demonstrated against male HLA-A2 target cells (target 
5-8). The converse effect was found after absorption with monolayer 3 (HLA-B7 
male) and, in this case, the reaction directed to HLA-B7 males was specifically 
depleted. Double absorption further depleted the killer cell clones, but because of the 
limited amount of material available, it was not possible to perform this in all cases 
(E. Goulmy, unpublished results). The most effective reduction (up to 82%) in 
cytotoxicity was obtained with monolayer 4 (HLA-A2 and HLA-B7 male). Killing 
activity directed to the target cells which carried both restricting HLA antigens 
(HLA-A2 and HLA-B7), was only partially reduced after absorption with an HLA- 
A2 male monolayer (monolayer 1), or HLA-B7 male monolayer (monolayer 3). These 
results provide strong evidence that the anti-B7 clone could be absorbed independently 
of the anti-A2 clone. 
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TABLE I 
Absorption of the Anti-H-Y," HLA-A2 Cytotoxicity 
547 
Target HLA-A2 Sex 0* 
cell 
Monolayers 
1 2 3 4 
A2 ~ NonA2 C~ A2 t~ Non A2 
1 + d 61 ± 1.4 26 ::1:3.1 61 3= 1.6 54 ± 3.7 57 3= 3.9 
2 + d 82 3= 1.5 29 3= 1.1 80 3= 0.9 67 + 2.6 77 .4- 1.2 
3 + t3 70 3= 1.3 26 3= 1.2 71 ± 1.8 65 ± 1.7 69 ± 0.4 
4 + ~ 66 ± 0.7 35 ± 3.4 73 ± 1.2 67 ± 3.9 72 ± 3.5 
5 - c~ -9  ± 4.9 -7  ± 9.3 -5  ± 2.6 -6  ± 9.2 -4  ± 3.5 
6 - ~ -10  ± 0.7 -7  + 3.1 -5  3= 1.1 -7  ± 2.8 -4  3= 2.2 
7 - c~ -10  3= 6.6 -8  3= 4.5 -6  3= 3.8 -8  3= 5.5 -5  ± 1.6 
8 + ~ -8  + 4.6 -10  3= 3.5 -4  ± 3.8 -9  3= 3.1 -2  + 4.3 
9 + ~ -6  3= 5.3 -9  + 0.7 -3  3= 3.0 -9  ± 4.9 -2  3= 5.3 
l0 + ~ -1  ± 3.7 --4 3= 5.1 0 + 8.4 -2  3= 4.4 + 1 ± 3.3 
l l  + ~ -6  + 2.0 -2  3= 7.7 -6  3= 3.8 --8 ± 1.9 -4  3= 4.0 
12 - ~ -4  ± 9.1 -3  3= 3.7 0 3= 4.5 -2  3= 2.2 -1  + 5.5 
13 - 9 -6  3= 3.2 -8  + 3.6 -6  ± 2.4 -6  + 1.8 -4  3= 6.1 
14 - ~ -7  + 3.2 -7  3= 4.4 -3  3= 3.5 -6  3= 3.5 -3  ± 3.0 
Sensitized cells of patient A before and after absorption on different monolayers, tested on a panel of 
target cells (1-14). Phenotype of patient A: ~, HLA-A2, - ;  B12, w40; Cw3, - .  Effector: target ratio = 
50:1. Different ratios were tested (Not shown). The experiments were repeated at least once. ~,  percent 
lysis =t: variation coefficient. 
* Without absorption. Monolayers: 1. HLA-A2 male. 2. Non HLA-A2 male. 3. HLA-A2 female. 4. Non 
HLA-A2 female. 
TABLE I I 
HLA-A2 and HLA-B7 Restricted H- Y Killing Shown by Patient B*, Phenotype: HLA-A2, 28; B7, 15; 
Cw3, - 
CML 
Serological type of target 
HLA-A2 
÷ 
15 0 
CML 
8 11 
HLA-B7 
+ 
+ II 
- 3 
0 
II 
CML 
+ 
HLA-A2  
g 
I'5 
0 
Sex of the target 
o 
0 
HLA-B7 
d 
+ II 
CML 
- 0 
* Patient B was sensitized in vitro with lymphocytes of an HLA-A, -B, and -C identical, HLA-D different, 
unrelated male donor. 
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TABL~ III 
Independent Absorption of the Anti-HLA-A2; H- Y and Anti-HLA-B7; H- Y Cytotoxicity 
Target HLA-A2/- Sex O* 
cell HLA-B7 
Monolayers 
2 
1 3 4 
A2 d' Non A2 & B7 B7 ~ A2, B7 
Patient +/+ 9 0 ± 3.1 -1  ± 4.9 + 1 ± 3.0 0 ± 4.2 -3  ± 1.1 
1 +/+ d~ 89 ± 3.8 63 ± 3.2 85 ± 5.6 54 ± 4.6 38 ± 3.0 
2 +/+ d 84 ± 2.8 51 ± 2.8 78 ± 3.5 42 ± 3.3 24 ± 2.5 
3 +/+ d 87 ± 2.0 61 ± 3.5 81 ± 1.4 48 ± 3.7 28 ± 2.2 
4 +/+ d 60 ± 4.3 43 ± 4.7 52 ± 3.1 27 ± 1.1 15 ± 3.6 
5 +/ -  d 47 ± 1.1 9 ± 2.9 43 ± 3.5 33 ± 3.5 16 ± 3.0 
6 +/ -  d 47 ± 2.2 8 ± 4.8 41 ± 1.3 31 ± 3.7 12 ± 1.1 
7 +/ -  d 47 ± 4.0 14 ± 4.1 43 ± 3.1 32 ± 2.1 14 ± 2.4 
8 +/ -  d 57 ± 2.4 13 ± 3.9 44 ± 2.0 34 ± 1.6 16 ± 2.7 
9 - /+  ¢~ 65 ± 3.9 47 + 2.4 61 ± 1.3 25 ± 3.4 14 ± 2.4 
10 - /+  d 82 ± 3.5 64 ± 4.4 78 ± 2.6 32 ± 3.2 27 ± 0.7 
11 - /+  d 73 ± 0.6 52 ± 3.4 62 ± 2.7 24 ± 3.0 13 ± 0.8 
12 - / -  d 7 ± 1.5 0 ± 5.3 2 ± 2.1 3 ± 5.4 1 ± 5.2 
13 - / -  d 9 ± 3.5 4 ± 5.1 8 ± 5.0 0 ± 0.8 2 ± 2.1 
14 - / -  t3 2 ± 6.1 0 ± 4.0 1 ± 2.6 -1  ± 6.8 -2  ± 2.2 
Sensitized cells of patient B before and after absorption on different monolayers, tested on a panel of 
target cells (1-14). Phenotype of patient B: 9, HLA-A2, 28; B7, 15; Cw3, - .  Effector: target ratio 50:1. 
Different ratios were tested (not shown). The  experiments were repeated at least once. ~', percent lysis 
± variation coefficient. 
* Without absorption. Monolayers: 1. HLA-A2 male. 2. Non HLA-A2, Non HLA-B7 male. 3. HLA-B7 
male. 4. HLA°A2, HLA-B7 male. 
D iscuss ion  
The  reduct ion obta ined in the level o fcytotox ic i ty  in these exper iments  was thought  
to be at t r ibutab le  to removal  of  specific subpopulat ions of  effector cells by the 
mono layer  and not by admixed  soluble ant igen or cells detached from the monolayer .  
Exper iments  in mouse using a s imi lar system demonst rated  that  cells detached from 
the mono layer  were incapable  of  cold target inhib i t ion (18). These observat ions were 
conf i rmed in the human mono layer  absorpt ion techniques used here (15). 
We cannot  draw conclusions from these data  which favor altered self or dual  
recognit ion. In the former case, the clonal expression of  ki l l ing would fulfill the 
predict ion of  the clonal selection theory and altered self would  s imply be regarded as 
an al loant igen.  In the latter case, the clonal expression of  anti-self  would  imply  that 
allelic exclusion existed with regard to anti -self  HLA receptors, i.e. T-cel l  clones 
special ize in different HLA-A ,  -B, and -C gene products  of  the self type and are thus 
clonal ly expressed. Fur thermore ,  the avidity of  the two receptors (self and foreign) 
would be interdependent .  
Our  f indings are in agreement  with those of  others who observed that cytotoxic 
effector cells directed to virus- infected syngeneic ells could be blocked in cold target 
inhibit ion exper iments  only by the virus- infected syngeneic cells and not by virus- 
infected al logeneic ells. Thus,  self and foreign determinants  are required on the same 
cell to obta in  blocking (19). Th is  general  rule is conf i rmed here and extended by our 
exper iments  because they suggest that in man this anti-self  or altered-self  act iv i ty is 
c lonal ly expressed. The  advantage  of  the absorpt ion technique as used here is that 
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clones can be physically removed from cell suspensions, thus giving evidence for 
separate populations. In contrast, cold target inhibition studies result only in blocking 
of receptors and theoretically cannot distinguish between polyvalent and monovalent 
effector cells. Of  great interest was the observation that a small but significant 
reduction in lysis of B7 positive cells occurred after absorption on A2 monolayers and 
similarly, a reduction occurred in the killing of A2-positive cells after absorption on 
B7 monolayers. There was no clear explanation of this phenomenon but the possibility 
existed that it was attributable to clones of killer cells which recognized antigens that 
were shared by both A2 and B7 bearing molecules (20, 21). No reduction at all has 
been found using nonrelevant male or female monolayers. 
The possible relevance of these findings to the mechanisms involved in the initiation 
of autoimmune disease in man has been discussed elsewhere (22). 
Summary  
A monolayer absorption technique was used to test the hypothesis that killer cells 
directed to self HLA-associated minor histocompatibility antigens (H-Y) were divisible 
into subsets. The results showed that sensitized killer cells, which recognized two 
combined antigens HLA-A2; H-Y and HLA-B7; H-Y could indeed be divided into 
two populations. One was directed to HLA-A2; H-Y and the other to HLA-B7; H-Y. 
These results can be interpreted in the context of the altered self hypothesis. However, 
when interpreted in the context of the dual recognition hypothesis, they strongly 
suggest hat independant clones of killer T cells exist which are committed to the 
recognition of self HLA. 
We would like to thank Miss E. Blokland for her technical assistance and Miss J. C. G. van 
Nassau for her secretarial ssistance. 
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